BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36849230)

  • 1. Mortality Rates and autopsy findings in fat embolism syndrome complicating sickle cell disease.
    Samaee S; Samaee S; Mihalca D; Fitzgerald L; Ahmed A; Hall J; Tsitsikas DA
    J Clin Pathol; 2023 Jul; 76(7):497-500. PubMed ID: 36849230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal fat embolism syndrome in a child with undiagnosed hemoglobin S/beta+ thalassemia: a complication of acute parvovirus B19 infection.
    Kolquist KA; Vnencak-Jones CL; Swift L; Page DL; Johnson JE; Denison MR
    Pediatr Pathol Lab Med; 1996; 16(1):71-82. PubMed ID: 8963632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B19 parvovirus infection and transient aplastic crisis in a child with sickle cell anemia.
    Rao SP; Desai N; Miller ST
    J Pediatr Hematol Oncol; 1996 May; 18(2):175-7. PubMed ID: 8846133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection.
    Tsitsikas DA; Gallinella G; Patel S; Seligman H; Greaves P; Amos RJ
    Blood Rev; 2014 Jan; 28(1):23-30. PubMed ID: 24468004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of human parvovirus B19 in children with sickle cell disease.
    Smith-Whitley K; Zhao H; Hodinka RL; Kwiatkowski J; Cecil R; Cecil T; Cnaan A; Ohene-Frempong K
    Blood; 2004 Jan; 103(2):422-7. PubMed ID: 14525777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period.
    Rao SP; Miller ST; Cohen BJ
    Am J Dis Child; 1992 Nov; 146(11):1328-30. PubMed ID: 1415073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatic sequestration caused by parvovirus B19 infection in a patient with sickle cell anemia.
    Koduri PR; Patel AR; Pinar H
    Am J Hematol; 1994 Nov; 47(3):250-1. PubMed ID: 7942800
    [No Abstract]   [Full Text] [Related]  

  • 8. [Human parvovirus B19 infection in sickle cell disease patients. A two siblings report].
    Barberá Pérez P; Vidaller PP
    Rev Chilena Infectol; 2021 Feb; 38(1):114-118. PubMed ID: 33844801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of parvovirus B19 infection in children with aplastic crisis.
    Kellermayer R; Faden H; Grossi M
    Pediatr Infect Dis J; 2003 Dec; 22(12):1100-1. PubMed ID: 14688575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.
    Lowenthal EA; Wells A; Emanuel PD; Player R; Prchal JT
    Am J Hematol; 1996 Mar; 51(3):207-13. PubMed ID: 8619401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia.
    Regaya F; Oussaief L; Bejaoui M; Karoui M; Zili M; Khelifa R
    BMC Infect Dis; 2007 Oct; 7():123. PubMed ID: 17961236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human parvovirus infection in homozygous sickle cell disease.
    Serjeant GR; Serjeant BE; Thomas PW; Anderson MJ; Patou G; Pattison JR
    Lancet; 1993 May; 341(8855):1237-40. PubMed ID: 8098391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease.
    Quek L; Sharpe C; Dutt N; Height S; Allman M; Awogbade M; Rees DC; Zuckerman M; Thein SL
    Br J Haematol; 2010 Apr; 149(2):289-91. PubMed ID: 20064150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral microhaemorrhages secondary to fat embolus syndrome in sickle cell disease.
    Alobeidi F; Inusa BP; Singh RR; U-King-Im JM
    Postgrad Med J; 2015 Jan; 91(1071):55-6. PubMed ID: 25583740
    [No Abstract]   [Full Text] [Related]  

  • 15. Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism.
    Guo J; Wang Y; Zhang M; Zheng H; Zang Q; Huang P; Wen L; Song D; Yang F; Dong R; Miao W
    Front Cell Infect Microbiol; 2022; 12():1083839. PubMed ID: 36619750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 and recipient safety: is it time to do more?
    Stramer SL
    Transfus Med; 2020 Aug; 30(4):243-244. PubMed ID: 32567077
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients.
    Obeid OE
    J Infect Dev Ctries; 2011 Jul; 5(7):535-9. PubMed ID: 21795822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat Embolism Syndrome in Sickle Cell β-Thalassemia Patient With Osteonecrosis: An Uncommon Presentation in a Young Adult.
    Sangani V; Pokal M; Balla M; Merugu GP; Khokher W; Gayam V; Konala VM
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012266. PubMed ID: 34008428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 infection in patients with or without underlying diseases.
    Sim JY; Chang LY; Chen JM; Lee PI; Huang LM; Lu CY
    J Microbiol Immunol Infect; 2019 Aug; 52(4):534-541. PubMed ID: 31257106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human parvovirus B19 in sickle cell disease and healthy controls.
    Teuscher T; Baillod B; Holzer BR
    Trop Geogr Med; 1991; 43(1-2):108-10. PubMed ID: 1661040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.